Table 2. Safety and tolerability.
| Placebo | Curcumin | |
|---|---|---|
| Treatment-related adverse events, N | ||
| Diarrhea | 1 | 1 |
| Dizziness | 0 | 1 |
| Gastrointestinal discomfort | 2 | 1 |
| Nausea | 1 | 0 |
| Subjects with ≥ 1 adverse event, n | 0 | 0 |
| Excluded, N | 1 | 1 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.